| James A Dahl, MD | |
|
820 N Chelan Ave, Wenatchee, WA 98801-2028 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | James A Dahl |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 36 Years |
| Location | 820 N Chelan Ave, Wenatchee, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578592176 | NPI | - | NPPES |
| P01256384 | Other | WA | RR MEDICARE |
| 132599 | Other | WA | L&I |
| 1578592176 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD00035786 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Washington Hospital | Wenatchee, WA | Hospital |
| Quincy Valley Medical Center | Quincy, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Washington Health Services Association | 4880504596 | 645 |
News Archive
Media outlets report on a variety of implementation issues, including anti-trust concerns related to accountable care organizations as well as questions about the reform waiver process and a House committee chairman's efforts to reverse Medicare advantage cuts.
World class scientist Professor Willem M. de Vos will explain next Monday how the microbes that are closest to our hearts - gut microbes - could underpin a new way of thinking about human biology. As well as looking at our own genes, we can now include those of our microbes in studies of human health and disease. This is a significant shift in the way we approach human biology.
CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.
Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.
More than 85 percent of Utah small businesses - those with less than 25 employees - will be eligible for federal tax credits to help pay for employee health coverage according to two lobbying groups that favored the health overhaul, The Salt Lake Tribune reports. "The two organizations said 37,800 companies will qualify for the credit, worth up to 35 percent of a small business's premium costs in 2010. The credit increases to 50 percent in January" (Beebe, 7/15).
› Verified 1 days ago
| Entity Name | Central Washington Health Services Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801937453 PECOS PAC ID: 4880504596 Enrollment ID: O20031106000287 |
News Archive
Media outlets report on a variety of implementation issues, including anti-trust concerns related to accountable care organizations as well as questions about the reform waiver process and a House committee chairman's efforts to reverse Medicare advantage cuts.
World class scientist Professor Willem M. de Vos will explain next Monday how the microbes that are closest to our hearts - gut microbes - could underpin a new way of thinking about human biology. As well as looking at our own genes, we can now include those of our microbes in studies of human health and disease. This is a significant shift in the way we approach human biology.
CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.
Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.
More than 85 percent of Utah small businesses - those with less than 25 employees - will be eligible for federal tax credits to help pay for employee health coverage according to two lobbying groups that favored the health overhaul, The Salt Lake Tribune reports. "The two organizations said 37,800 companies will qualify for the credit, worth up to 35 percent of a small business's premium costs in 2010. The credit increases to 50 percent in January" (Beebe, 7/15).
› Verified 1 days ago
| Entity Name | Wenatchee Valley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669719688 PECOS PAC ID: 9537309869 Enrollment ID: O20130716000034 |
News Archive
Media outlets report on a variety of implementation issues, including anti-trust concerns related to accountable care organizations as well as questions about the reform waiver process and a House committee chairman's efforts to reverse Medicare advantage cuts.
World class scientist Professor Willem M. de Vos will explain next Monday how the microbes that are closest to our hearts - gut microbes - could underpin a new way of thinking about human biology. As well as looking at our own genes, we can now include those of our microbes in studies of human health and disease. This is a significant shift in the way we approach human biology.
CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.
Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.
More than 85 percent of Utah small businesses - those with less than 25 employees - will be eligible for federal tax credits to help pay for employee health coverage according to two lobbying groups that favored the health overhaul, The Salt Lake Tribune reports. "The two organizations said 37,800 companies will qualify for the credit, worth up to 35 percent of a small business's premium costs in 2010. The credit increases to 50 percent in January" (Beebe, 7/15).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James A Dahl, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: () - | James A Dahl, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 |
News Archive
Media outlets report on a variety of implementation issues, including anti-trust concerns related to accountable care organizations as well as questions about the reform waiver process and a House committee chairman's efforts to reverse Medicare advantage cuts.
World class scientist Professor Willem M. de Vos will explain next Monday how the microbes that are closest to our hearts - gut microbes - could underpin a new way of thinking about human biology. As well as looking at our own genes, we can now include those of our microbes in studies of human health and disease. This is a significant shift in the way we approach human biology.
CytRx Corporation, a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced soft tissue sarcomas who have failed surgery and radiation. Soft tissue sarcomas are cancers that are formed in the muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.
Immune suppressor cells called MDSCs (myeloid-derived suppressor cells) may be important in developing treatments for advanced prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.
More than 85 percent of Utah small businesses - those with less than 25 employees - will be eligible for federal tax credits to help pay for employee health coverage according to two lobbying groups that favored the health overhaul, The Salt Lake Tribune reports. "The two organizations said 37,800 companies will qualify for the credit, worth up to 35 percent of a small business's premium costs in 2010. The credit increases to 50 percent in January" (Beebe, 7/15).
› Verified 1 days ago
Sean Caskey, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 520 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-662-8756 | |
Jeffrey Allan Pratt, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-662-2211 Fax: 509-662-8756 | |
Dr. Mark A. Broberg, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-662-2211 Fax: 509-662-8756 | |
Eric Thorson, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Roger J Starkweather, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 304 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-662-3838 Fax: 509-663-1108 | |
Dr. Keary P. Kunz, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 520 N Chelan Ave, Wenatchee Orthopaedics, Wenatchee, WA 98801 Phone: 509-662-2211 Fax: 509-662-8756 | |
Benjamin Albertson, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 |